Suchergebnisse - "Legendre, Paul"

PubPharm (31)

11

Efficacy of baricitinib for refractory large-vessel vasculitis

enthalten in: Rheumatology (Oxford, England) | 2021

von Régent, A. | Terrier, B. | Legendre, P. | +4

12

High D-dimer plasma concentration in systemic sclerosis patients : Prevalence and association with vascular complications

enthalten in: Journal of scleroderma and related disorders | 2021

von Furtado, S. | Dunogué, B. | Jourdi, G. | +4

13

Corticosteroids in patients hospitalized for COVID-19 pneumonia who require oxygen : observational comparative study using routine care data

enthalten in: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases | 2021

von Tran, V. | Mahévas, M. | Bani-Sadr, F. | +108

14

Mycophenolic acid drug monitoring in patients with systemic sclerosis associated with diffuse skin and/or pulmonary involvement : A monocentric and retrospective French study

enthalten in: Journal of scleroderma and related disorders | 2021

von Legendre, P. | Blanchet, B. | Porcher, R. | +7

15

Plasma Concentrations and Safety of Lopinavir/Ritonavir in COVID-19 Patients

enthalten in: Therapeutic drug monitoring | 2021

von Chouchana, L. | Boujaafar, S. | Gana, I. | +13

16

No evidence of clinical efficacy of hydroxychloroquine in patients hospitalised for COVID-19 infection and requiring oxygen: results of a study using routinely collected data to emulate a target trial

enthalten in: bioRxiv.org | 2020

von Mahévas, M. | Tran, V. | Roumier, M. | +27

17

Plasma concentration and safety of lopinavir/ritonavir in patients with Covid-19: a short communication

enthalten in: bioRxiv.org | 2020

von Chouchana, L. | Boujaafar, S. | Gana, I. | +12

18

Risk of scleroderma according to the type of immune checkpoint inhibitors

enthalten in: Autoimmunity reviews | 2020

von Terrier, B. | Humbert, S. | Preta, L. | +15

19

Catastrophic antiphospholipid syndrome following the introduction of rivaroxaban

enthalten in: Lupus | 2020

von Stammler, R. | Legendre, P. | Cacoub, P. | +3

20

Utilization of intravenous or subcutaneous immunoglobulins in secondary immune deficiency (ULTIMATE) : A retrospective multicenter study

enthalten in: Clinical immunology (Orlando, Fla.) | 2020

von Legendre, P. | Chahwan, D. | Marjanovic, Z. | +15